News

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
Novavax Inc. closed 61.59% short of its 52-week high of $17.81, which the company achieved on July 26th.
Novavax Inc. closed 60.47% below its 52-week high of $17.81, which the company achieved on July 26th.
Novavax stock was up on Monday amid roiling uncertainty about its Covid-19 vaccine approval, which has been caught up in the turbid health politics of the second Trump administration. Novavax said ...
Novavax faces a couple of key issues that could be crucial for the stock price. Novavax ( NVAX 0.67% ) soared more than 2,700% early in the pandemic as investors bet on its ability to bring a ...
Novavax, Inc. shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look at what's going on.
Novavax (NASDAQ: NVAX) has been a highly volatile stock in recent years, and that volatility is on full display again this month. Shares of the healthcare stock are up 200% since the start of May.